NCT02459730

Brief Summary

This study evaluated the clinical and microbiological long-term effects of 1.25% CHX associated with GIC applied in primary molars using Atraumatic Restorative Treatment (ART) technique. Randomized controlled trial was conducted on 40 children with carious lesions that received ART either with GIC containing CHX or GIC only. Survival rate of restorations was checked at 3 days, 3 months and 1 year after their placement when the unstimulated saliva samples were collected for microbiological assessment of mutans streptococci (MS) counts. Data were analyzed using ANOVA/Tukey or Kruskal-Wallis/Mann-Whitney tests (p \<0.05).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 2, 2015

Completed
Last Updated

June 2, 2015

Status Verified

May 1, 2015

Enrollment Period

Same day

First QC Date

May 13, 2015

Last Update Submit

May 28, 2015

Conditions

Keywords

Dental cariesglass ionomer cementART

Outcome Measures

Primary Outcomes (1)

  • Clinical long-term effect - Survival Rate

    Randomized controlled trial was conducted on 40 children with carious lesions that received ART either with GIC containing CHX or GIC only. Survival rate of restorations was checked after 7 days, 3 months and 1 year of their placement.

    up to 1 year after restorative procedure

Secondary Outcomes (1)

  • Microbiological long-term effect (microbiological assessment of mutans streptococci (MS) counts)

    up to 1 year after restorative procedure

Study Arms (2)

ART with GIC containing 1.25% CHX

EXPERIMENTAL

The cavities were filled with the press finger technique using GIC KetacMolar Easymix® containing 1.25% chlorhexidine digluconate (n= 41 tooth surfaces).

Procedure: ART with GIC containing 1.25% CHX.

ART with GIC

ACTIVE COMPARATOR

The cavities were filled with the press finger technique using KetacMolar Easymix® (control group).

Procedure: ART with GIC.

Interventions

Carious lesions were prepared by removing infected dentin with hand instruments. No local anesthesia was administered. Then, the cavities were filled with the press finger technique using GIC KetacMolar Easymix® containing 1.25% chlorhexidine digluconate (n= 41 tooth surfaces).

ART with GIC containing 1.25% CHX
ART with GIC.PROCEDURE

Carious lesions were prepared by removing infected dentin with hand instruments. No local anesthesia was administered. Then, the cavities were filled with the press finger technique using KetacMolar Easymix® (n = 66 tooth surfaces).

ART with GIC

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Good general health
  • At least one cavitated dentin carious lesion in primary molars or incisors that had an opening wide enough for the smallest ART excavator access

You may not qualify if:

  • Teeth with pulpal exposure or the presence of fistula and history of pain were excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoctoral scholar

Study Record Dates

First Submitted

May 13, 2015

First Posted

June 2, 2015

Study Start

February 1, 2013

Primary Completion

February 1, 2013

Study Completion

February 1, 2014

Last Updated

June 2, 2015

Record last verified: 2015-05